nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.21682/2311-1267-2019-6-3-31-43nodgo-524Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESФакторы риска по данным визуализации у пациентов с нейробластомой. Обзор литературыImage defined risk factors in patients with neuroblastoma. Literature reviewhttps://orcid.org/0000-0002-9426-0676ТерноваяЕ. С.TernovayaE. S.

Екатерина Сергеевна Терновая

врач рентгенологического отделения

117997, Москва, ул. Саморы Машела, 1

Physician of Radiology Department

1 Samory Mashela St., Moscow, 117997

ekaterina.ternovaya@fccho-moscow.comhttps://orcid.org/0000-0002-3704-8783КачановД. Ю.KachanovD. Yu.

д.м.н., заведующий отделением клинической онкологии, заместитель директора Института онкологии, радиологиии ядерной медицины, SPIN-код: 9878-5540

117997, Москва, ул. Саморы Машела, 1

Dr. of Sci. (Med.), Head of the Department of Clinical Oncology, Deputy Director of the Institute of Oncology, Radiology and Nuclear Medicine

1 Samory Mashela St., Moscow, 117997

denis.kachanov@fccho-moscow.ruhttps://orcid.org/0000-0002-3767-4477ШаманскаяТ. В.ShamanskayaT. V.

к.м.н., ученый секретарь Института онкологии, радиологии и ядерной медицины

117997, Москва, ул. Саморы Машела, 1

Cand. of Sci. (Med.), Scientific Secretary of the Institute of Oncology, Radiology and Nuclear Medicine

1 Samory Mashela St., Moscow, 117997

shamanskaya.tatyana@gmail.comhttps://orcid.org/0000-0001-8129-0545ЩербаковА. П.ShcherbakovA. P.

врач рентгенологического отделения НМИЦ ДГОИ им. Дмитрия Рогачева

117997, Москва, ул. Саморы Машела, 1

Physician of Radiology Department

1 Samory Mashela St., Moscow, 117997

Alexey.Shcherbakov@fccho-moscow.ruhttps://orcid.org/0000-0001-6131-1783ВарфоломееваС. Р.VarfolomeevaS. R.

д.м.н., профессор, заместитель директора по научной и лечебной работе – директор;

исполнительный директор РОО НОДГО;

115478, Москва, Каширское шоссе, 23

Dr. of Sci. (Med.), Professor, Deputy Director for Research and Clinical Work – Director, Executive Director of Regional Public Organization National Society of Pediatric Hematologists and Oncologists

23 Kashirskoe Shosse, Moscow, 115478

clinoncology@gmail.comРубцоваН. А.RubtsovaN. A.

д.м.н., руководитель отдела лучевой диагностики

125284, Москва, 2-й Боткинский пр., 3

Dr. of Sci. (Med.), Head of the Department Radiation Diagnosis

3 2nd Botkinskiy Proezd,Moscow, 125284

rna17@yandex.ruhttps://orcid.org/0000-0001-7317-7104ТерещенкоГ. В.TereshchenkoG. V.

к.м.н., врач-рентгенолог, заведующая рентгенологическим отделением

117997, Москва, ул. Саморы Машела, 1

Cand. of Sci. (Med.), Radiologist, Head of the Radiology Department

1 Samory Mashela St., Moscow, 117997

galina.tereshenko@fccho-moscow.ruФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaRussian FederationНИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава РоссииРоссияResearch Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of RussiaRussian FederationМосковский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава РоссииРоссияP.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Center of Radiology, Ministry of Health of RussiaRussian Federation201922092019633143Copyright © Терновая Е.С., Качанов Д.Ю., Шаманская Т.В., Щербаков А.П., Варфоломеева С.Р., Рубцова Н.А., Терещенко Г.В., 20192019Терновая Е.С., Качанов Д.Ю., Шаманская Т.В., Щербаков А.П., Варфоломеева С.Р., Рубцова Н.А., Терещенко Г.В.Ternovaya E.S., Kachanov D.Y., Shamanskaya T.V., Shcherbakov A.P., Varfolomeeva S.R., Rubtsova N.A., Tereshchenko G.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/524

В настоящее время используются 2 системы стадирования пациентов с нейробластомой (НБ): Международная система стадирования НБ (INSS), которая опирается на данные хирургического этапа лечения, и Международная система стадирования групп риска НБ (INRGSS), которая основывается на данных предоперационной визуализации пациентов и выявляемых факторах риска. В статье представлен обзор литературы, посвященный данным факторам риска, методам их диагностики (компьютерной и магнитно-резонансной томографии) у пациентов с НБ, методике их описания, распространенности на этапе первичной диагностики и влиянию на результаты хирургического лечения и прогноз заболевания.

Currently, two staging systems are used: the International Neuroblastoma Staging System (INSS), which relies on surgical staging, and the International Neroblastoma Risk Group Stading System (INRGSS), which relies on preoperative imaging for staging and image-defined risk. The article presents a review of the literature on image defined risk factors (IDRF) determined during radiological studies (computed tomography and magnetic resonance imaging) in patients with neuroblastoma. The article focuses on the definition of IDRFs, their prevalence and their influence on surgical outcomes and prognosis of patients with neuroblastoma.

нейробластомафакторы риска по данным визуализациидетиINSSINRGSSneuroblastomaimage defined risk factorschildrenINSSINRGSSReferencesMiller R.W., Young J.L. Jr., Novakovic B. Childhood cancer. Cancer 1995;75(1 Suppl):395–405. doi: 10.1002/1097-0142(19950101)75:1+<395::aid-cncr2820751321>3.0.co;2-w.Miller R.W., Young J.L. Jr., Novakovic B. Childhood cancer. Cancer 1995;75(1 Suppl):395–405. doi: 10.1002/1097-0142(19950101)75:1+<395::aid-cncr2820751321>3.0.co;2-w.Juárez-Ocaña S., Palma-Padilla V., González-Miranda G., SiordiaReyes A.G., López-Aguilar E., Aguilar-Martínez M., Mejía-Aranguré J.M., Carreón-Cruz R., Rendón-Macías M.E., Fajardo-Gutiérrez A. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996–2005). BMC Cancer 2009;9:266. doi: 10.1186/1471-2407-9-266.Juárez-Ocaña S., Palma-Padilla V., González-Miranda G., SiordiaReyes A.G., López-Aguilar E., Aguilar-Martínez M., Mejía-Aranguré J.M., Carreón-Cruz R., Rendón-Macías M.E., Fajardo-Gutiérrez A. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996–2005). BMC Cancer 2009;9:266. doi: 10.1186/1471-2407-9-266.Grovas A., Fremgen A., Rauck A., Ruymann F.B., Hutchinson C.L., Winchester D.P., Menck H.R. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997;80(12):2321–32. doi: 10.1002/(sici)1097-0142(19971215)80:12<2321::aid-cncr14>3.0.co;2-w.Grovas A., Fremgen A., Rauck A., Ruymann F.B., Hutchinson C.L., Winchester D.P., Menck H.R. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997;80(12):2321–32. doi: 10.1002/(sici)1097-0142(19971215)80:12<2321::aid-cncr14>3.0.co;2-w.Nour-Eldin N.E., Abdelmonem O., Tawfi k A.M., Naguib N.N., Klingebiel T., Rolle U., Schwabe D., Harth M., Eltoukhy M.M., Vogl T.J. Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review. Magn Reson Imaging 2012;30(7):893–906. doi: 10.1016/j.mri.2012.02.028.Nour-Eldin N.E., Abdelmonem O., Tawfi k A.M., Naguib N.N., Klingebiel T., Rolle U., Schwabe D., Harth M., Eltoukhy M.M., Vogl T.J. Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review. Magn Reson Imaging 2012;30(7):893–906. doi: 10.1016/j.mri.2012.02.028.Vo K.T., Matthay K.K., Neuhaus J., London W.B., Hero B., Ambros P.F., Nakagawara A., Miniati D., Wheeler K., Pearson A.D., Cohn S.L., DuBois S.G. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol 2014;32(28):3169–76. doi: 10.1200/JCO.2014.56.1621.Vo K.T., Matthay K.K., Neuhaus J., London W.B., Hero B., Ambros P.F., Nakagawara A., Miniati D., Wheeler K., Pearson A.D., Cohn S.L., DuBois S.G. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol 2014;32(28):3169–76. doi: 10.1200/JCO.2014.56.1621.Alvi S., Karadaghy O., Manalang M., Weatherly R. Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol 2017;97:157–62. doi: 10.1016/j.ijporl.2017.04.013.Alvi S., Karadaghy O., Manalang M., Weatherly R. Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol 2017;97:157–62. doi: 10.1016/j.ijporl.2017.04.013.McCarville M.B. Imaging neuroblastoma: what the radiologist needs to know. Cancer Imaging 2011;11 Spec No A:S44–7. doi: 10.1102/1470-7330.2011.9008.McCarville M.B. Imaging neuroblastoma: what the radiologist needs to know. Cancer Imaging 2011;11 Spec No A:S44–7. doi: 10.1102/1470-7330.2011.9008.Cecchetto G., Mosseri V., De Bernardi B., Helardot P., Monclair T., Costa E., Horcher E., Neuenschwander S., Tomà P., Rizzo A., Michon J., Holmes K. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 2005;23(33):8483–9. doi: 10.1200/JCO.2005.02.4661.Cecchetto G., Mosseri V., De Bernardi B., Helardot P., Monclair T., Costa E., Horcher E., Neuenschwander S., Tomà P., Rizzo A., Michon J., Holmes K. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 2005;23(33):8483–9. doi: 10.1200/JCO.2005.02.4661.Cohn S.L., Pearson A.D., London W.B., Monclair T., Ambros P.F., Brodeur G.M., Faldum A., Hero B., Iehara T., Machin D., Mosseri V., Simon T., Garaventa A., Castel V., Matthay K.K.; INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009;27(2):289–97. doi: 10.1200/JCO.2008.16.6785.Cohn S.L., Pearson A.D., London W.B., Monclair T., Ambros P.F., Brodeur G.M., Faldum A., Hero B., Iehara T., Machin D., Mosseri V., Simon T., Garaventa A., Castel V., Matthay K.K.; INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009;27(2):289–97. doi: 10.1200/JCO.2008.16.6785.Brisse H.J., McCarville M.B., Granata C., Krug K.B., WoottonGorges S.L., Kanegawa K., Giammarile F., Schmidt M., Shulkin B.L., Matthay K.K., Lewington V.J., Sarnacki S., Hero B., Kaneko M., London W.B., Pearson A.D., Cohn S.L, Monclair T.; International Neuroblastoma Risk Group Project. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261(1):243–57. doi: 10.1148/radiol.11101352.Brisse H.J., McCarville M.B., Granata C., Krug K.B., WoottonGorges S.L., Kanegawa K., Giammarile F., Schmidt M., Shulkin B.L., Matthay K.K., Lewington V.J., Sarnacki S., Hero B., Kaneko M., London W.B., Pearson A.D., Cohn S.L, Monclair T.; International Neuroblastoma Risk Group Project. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261(1):243–57. doi: 10.1148/radiol.11101352.Monclair T., Mosseri V., Cecchetto G., De Bernardi B., Michon J., Holmes K. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer 2015;62(9):1536–42. doi: 10.1002/pbc.25460.Monclair T., Mosseri V., Cecchetto G., De Bernardi B., Michon J., Holmes K. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer 2015;62(9):1536–42. doi: 10.1002/pbc.25460.Качанов Д.Ю. Результаты риск-адаптированной терапии нейробластомы у детей. Автореф. дис. … д-ра мед. наук. М., 2017. 64 с.Kachanov D.Yu. Results of the risk-adapted therapy of neuroblastoma in children. Thesis abstract of … Dr. of Sci. (Med.). M., 2017. 64 p. (In Russ.)Pohl A., Erichsen M., Stehr M., Hubertus J., Bergmann F., Kammer B., von Schweinitz D. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma. Klin Padiatr 2016;228(3):118–23. doi: 10.1055/s-0041-111175.Pohl A., Erichsen M., Stehr M., Hubertus J., Bergmann F., Kammer B., von Schweinitz D. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma. Klin Padiatr 2016;228(3):118–23. doi: 10.1055/s-0041-111175.Талыпов С.Р., Рачков В.Е., Сухов М.Н., Ускова Н.Г., Меркулов Н.Н., Андреев Е.С. Хирургическое лечение детей с нейробластомами торакальной локализации. Онкопедиатрия 2015;2(3):344–5.Talypov S.R., Rachkov V.E., Sukhov M.N., Uskova N.G., Merkulov N.N., Andreev E.S. Surgical treatment of children with thoracic neuroblastomas. Onkopediatriya = Oncopediatria 2015;2(3):344–5. (In Russ.)Irtan S., Brisse H.J., Minard-Colin V., Schleiermacher G., Canale S., Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and imagedefined risk factors. Pediatr Blood Cancer 2015;62(2):257–61. doi: 10.1002/pbc.25248.Irtan S., Brisse H.J., Minard-Colin V., Schleiermacher G., Canale S., Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and imagedefined risk factors. Pediatr Blood Cancer 2015;62(2):257–61. doi: 10.1002/pbc.25248.Simon T., Hero B., Benz-Bohm G., von Schweinitz D., Berthold F. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatr Blood Cancer 2008;50(5):965–9. doi: 10.1002/pbc.21343.Simon T., Hero B., Benz-Bohm G., von Schweinitz D., Berthold F. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatr Blood Cancer 2008;50(5):965–9. doi: 10.1002/pbc.21343.Поляков В.Г., Рябов А.Б., Ким Э.Ф., Лебедев В.И., Казанцев А.П., Керимов П.А., Рубанский М.А., Нечушкина И.В., Капкова О.А., Рубанская М.А., Рыбакова Д.В. Хирургический метод при опухолях торакоабдоминальной локализации у детей: современное состояние проблемы и опыт клиники. Онкопедиатрия 2014;1(1):13–9.Polyakov V.G., Ryabov A.B., Kim E.F., Lebedev V.I., Kazantsev A.P., Kerimov P.A., Rubansky M.A., Nechushkina I.V., Kapkova O.A., Rubanskaya M.A., Rybakova D.V. Surgical methodology for tumors of thoraco-abdominal localization in children. State of the art and the experience of the clinic. Onkopediatriya = Oncopediatria 2014;1(1):13–9. (In Russ.)Андреев Е.С., Сухов М.Н., Качанов Д.Ю., Варфоломеева С.Р., Рачков В.Е. Эндохирургическое лечение нейробластом у детей. Злокачественные опухоли 2013;(2):162.Andreev E.S., Sukhov M.N., Kachanov D.Yu., Varfolomeeva S.R., Rachkov V.E. Endosurgical treatment of neuroblastoma in children. Zlokachestvennye opukholi = Malignant Tumors 2013;(2):162. (In Russ.)Андреев Е.С., Сухов М.Н., Качанов Д.Ю., Варфоломеева С.Р., Рачков В.Е. Хирургическое лечение местнораспространенных нейробластом торако-абдоминальной локализации у детей. Злокачественные опухоли 2013;(2):187.Andreev E.S., Sukhov M.N., Kachanov D.Yu., Varfolomeeva S.R., Rachkov V.E. Surgical treatment of locally advanced neuroblastomas of thoraco-abdominal localization in children. Zlokachestvennye opukholi = Malignant Tumors 2013;(2):187. (In Russ.)Kushner B.H. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004;45(7):1172–88. PMID: 15235064.Kushner B.H. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004;45(7):1172–88. PMID: 15235064.Руцкая Е.А., Пролесковская И.В., Ретровская А.А., Маслова Д.А. К вопросу о визуально определяемых факторах риска в стадировании нейробластом. Онкопедиатрия 2016;3(2):157.Rutskaya E.A., Proleskovskaya I.V., Retrovskaya A.A., Maslova D.A. On the issue of image defined risk factors in neuroblastoma staging. Onkopediatriya = Oncopediatria 2016;3(2):157. (In Russ.)Тюрин И.Е. Лучевая диагностика в онкологии. Практическая онкология 2005;6(1):7–8.Tyurin I.E. Oncological radiology. Prakticheskaya onkologiya = Practical Oncology 2005; 6(1):7–8. (In Russ.)Прокоп М., Галански М. Спиральная и многослойная компьютерная томография: учебное пособие в 2 томах. М.: МЕДпрессинформ, 2009. 416 с.Prokop M., Galanski M. Spiral and multilayer computed tomography: a training manual in 2 vol. M.: MEDpressinform, 2009. 416 p. (In Russ.)Шаманская Т.В., Качанов Д.Ю., Лихоткина В.И., Терещенко Г.В., Терновая Е.С., Щербаков А.П., Ликарь Ю.Н., Рощин В.Ю., Ольшанская Ю.В., Казакова А.Н., Варфоломеева С.Р. Легочные метастазы при нейробластоме у детей. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2018;17(2):92–102. doi: 10.24287/1726-1708-2018-17-2-92-102.Shamanskaya T.V., Kachanov D.Yu., Lihotkina V.I., Tereschenko G.V., Ternovaya E.S., Scherbakov A.P., Likar Yu.N., Roshchin V.Yu., Olshanskaya Yu.V., Kazakova A.N., Varfolomeeva S.R. Lung metastases in childhood neuroblastoma. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2018;17(2):92–102. (In Russ.) doi: 10.24287/1726-1708-2018-17-2-92-102Stark D.D., Moss A.A., Brasch R.C., deLorimier A.A., Albin A.R., London D.A., Gooding C.A. Neuroblastoma: diagnostic imaging and staging. Radiology 1983;148(1):101–5. doi: 10.1148/radiology.148.1.6856817.Stark D.D., Moss A.A., Brasch R.C., deLorimier A.A., Albin A.R., London D.A., Gooding C.A. Neuroblastoma: diagnostic imaging and staging. Radiology 1983;148(1):101–5. doi: 10.1148/radiology.148.1.6856817.Hiorns M.P., Owens C.M. Radiology of neuroblastoma in children. Eur Radiol 2001;11(10):2071–81. doi: 10.1007/s003300100931.Hiorns M.P., Owens C.M. Radiology of neuroblastoma in children. Eur Radiol 2001;11(10):2071–81. doi: 10.1007/s003300100931.Кириллова О.А., Волкова Л.Д., Михайлова Е.В., Захарова Е.В., Поляков В.Г., Казанцев А.П. Клинические особенности и лучевая диагностика интрапаравертебральной нейробластомы у детей. Онкопедиатрия 2015;2(2):121–30. doi: 10.15690/onco.v2.i2.1343.Kirillova O.A., Volkova L.D., Mikhailova E.V., Zakharova E.V., Polyakov V.G., Kazantsev A.P. Clinical features and radiology of intraparavertebral neuroblastoma in children. Onkopediatriya = Oncopediatria 2015;2(2):121–30. (In Russ.) doi: 10.15690/onco.v2.i2.1343.Monclair T., Brodeur G.M., Ambros P.F., Brisse H.J., Cecchetto G., Holmes K., Kaneko M., London W.B., Matthay K.K., Nuchtern J.G., von Schweinitz D., Simon T., Cohn S.L., Pearson A.D.; INRG Task Force. The International risk roup (INRG) staging system: an INRG task force report. J Clin Oncol 2009;27(2):298–303. doi: 10.1200/JCO.2008.16.6876.Monclair T., Brodeur G.M., Ambros P.F., Brisse H.J., Cecchetto G., Holmes K., Kaneko M., London W.B., Matthay K.K., Nuchtern J.G., von Schweinitz D., Simon T., Cohn S.L., Pearson A.D.; INRG Task Force. The International risk roup (INRG) staging system: an INRG task force report. J Clin Oncol 2009;27(2):298–303. doi: 10.1200/JCO.2008.16.6876.Lim I.I., Goldman D.A., Farber B.A., Murphy J.M., Abramson S.J., Basu E., Roberts S., LaQuaglia M.P., Price A.P. Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection. J Pediatr Surg 2016;51(6):975–80. doi: 10.1016/j.jpedsurg.2016.02.069.Lim I.I., Goldman D.A., Farber B.A., Murphy J.M., Abramson S.J., Basu E., Roberts S., LaQuaglia M.P., Price A.P. Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection. J Pediatr Surg 2016;51(6):975–80. doi: 10.1016/j.jpedsurg.2016.02.069.Yoneda A., Nishikawa M., Uehara S., Oue T., Usui N., Inoue M., Fukuzawa M., Okuyama H. Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma? Eur J Pediatr Surg 2016;26(1):117–22. doi: 10.1055/s-0035-1566100.Yoneda A., Nishikawa M., Uehara S., Oue T., Usui N., Inoue M., Fukuzawa M., Okuyama H. Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma? Eur J Pediatr Surg 2016;26(1):117–22. doi: 10.1055/s-0035-1566100.Fumino S., Kimura K., Iehara T., Nishimura M., Nakamura S., Souzaki R., Nishie A., Taguchi T., Hosoi H., Tajiri T. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan. J Pediatr Surg 2015;50(12):2102–6. doi: 10.1016/j.jpedsurg.2015.08.039.Fumino S., Kimura K., Iehara T., Nishimura M., Nakamura S., Souzaki R., Nishie A., Taguchi T., Hosoi H., Tajiri T. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan. J Pediatr Surg 2015;50(12):2102–6. doi: 10.1016/j.jpedsurg.2015.08.039.Качанов Д.Ю., Шаманская Т.В., Муфтахова Г.М., Панкратьева Л.Л., Андреев Е.С., Грачёв Н.С., Талыпов С.Р., Терещенко Г.В., Хамин И.Г., Ольшанская Ю.В., Нечеснюк А.В., Рощин В.Ю., Добреньков К.В., Новичкова Г.А., Варфоломеева С.Р. Терапия пациентов с 4S-стадией нейробластомы: опыт ФГБУ «ФНКЦ ДГОИ им. Дмитрия Рогачёва». Онкопедиатрия 2015;2(3):278.Kachanov D.Yu., Shamanskaya T.V., Muftakhova G.M., Pankratieva L.L., Andreev E.S., Grachev N.S., Talypov S.R., Tereshchenko G.V., Khamin I.G., Olshanskaya Yu.V., Nechesnyuk A.V., Roshchin V.Yu., Dobrenkov K.V., Novichkova G.A., Varfolomeeva S.R. Therapy of patients with 4S-stage neuroblastoma: the experience of the Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology. Onkopediatriya = Oncopediatria 2015;2(3):278. (In Russ.)Avanzini S., Pio L., Erminio G., Granata C., Holmes K., Gambart M., Buffa P., Castel V., Valteau Couanet D., Garaventa A., Pistorio A., Cecchetto G., Martucciello G., Mattioli G., Sarnacki S. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer 2017;64(11). doi: 10.1002/pbc.26605.Avanzini S., Pio L., Erminio G., Granata C., Holmes K., Gambart M., Buffa P., Castel V., Valteau Couanet D., Garaventa A., Pistorio A., Cecchetto G., Martucciello G., Mattioli G., Sarnacki S. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer 2017;64(11). doi: 10.1002/pbc.26605.Siegel M.J., Ishwaran H., Fletcher B.D., Meyer J.S., Hoffer F.A., Jaramillo D., Hernandez R.J., Roubal S.E., Siegel B.A., Caudry D.J., McNeil B.J. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 2002;223(1):168–75. doi: 10.1148/radiol.2231010841.Siegel M.J., Ishwaran H., Fletcher B.D., Meyer J.S., Hoffer F.A., Jaramillo D., Hernandez R.J., Roubal S.E., Siegel B.A., Caudry D.J., McNeil B.J. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 2002;223(1):168–75. doi: 10.1148/radiol.2231010841.Günther P., Holland-Cunz S., Schupp C.J., Stockklausner C., Hinz U., Schenk J.P. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma. Eur J Pediatr Surg 2011;21(5):314–7. doi: 10.1055/s-0031-1280824.Günther P., Holland-Cunz S., Schupp C.J., Stockklausner C., Hinz U., Schenk J.P. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma. Eur J Pediatr Surg 2011;21(5):314–7. doi: 10.1055/s-0031-1280824.Tanaka Y., Kawashima H., Mori M., Fujiogi M., Suzuki K., Amano H., Morita K., Arakawa Y., Koh K., Oguma E., Iwanaka T., Uchida H. Contraindications and image-defined risk factors in laparoscopic resection of abdominal neuroblastoma. Pediatr Surg Int 2016;32(9):845–50. doi: 10.1007/s00383-016-3932-z.Tanaka Y., Kawashima H., Mori M., Fujiogi M., Suzuki K., Amano H., Morita K., Arakawa Y., Koh K., Oguma E., Iwanaka T., Uchida H. Contraindications and image-defined risk factors in laparoscopic resection of abdominal neuroblastoma. Pediatr Surg Int 2016;32(9):845–50. doi: 10.1007/s00383-016-3932-z.Yoneda A., Nishikawa M., Uehara S., Oue T., Usui N., Inoue M., Fukuzawa M., Okuyama H. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis? Pediatr Surg Int 2016;32(3):209–14. doi: 10.1007/s00383-016-3858-5.Yoneda A., Nishikawa M., Uehara S., Oue T., Usui N., Inoue M., Fukuzawa M., Okuyama H. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis? Pediatr Surg Int 2016;32(3):209–14. doi: 10.1007/s00383-016-3858-5.Irtan S., Brisse H.J., Minard-Colin V., Schleiermacher G., GalmicheRolland L., Le Cossec C., Elie C., Canale S., Michon J., ValteauCouanet D., Sarnacki S. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer 2015;62(9):1543–9. doi: 10.1002/pbc.25511.Irtan S., Brisse H.J., Minard-Colin V., Schleiermacher G., GalmicheRolland L., Le Cossec C., Elie C., Canale S., Michon J., ValteauCouanet D., Sarnacki S. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer 2015;62(9):1543–9. doi: 10.1002/pbc.25511.Shirota C., Tainaka T., Uchida H., Hinoki A., Chiba K., Tanaka Y. Laparoscopic resection of neuroblastomas in low- to high-risk patients without image-defined risk factors is safe and feasible. BMC Pediatr 2017;17(1):71. doi: 10.1186/s12887-017-0826-8.Shirota C., Tainaka T., Uchida H., Hinoki A., Chiba K., Tanaka Y. Laparoscopic resection of neuroblastomas in low- to high-risk patients without image-defined risk factors is safe and feasible. BMC Pediatr 2017;17(1):71. doi: 10.1186/s12887-017-0826-8.

The authors declare that there are no conflicts of interest present.